Maculopathy can occur following use of apixaban, paclitaxel, ibrutinib, and sildenafil, according to research published in ...

The FDA has expanded the approval of Yuflyma (adalimumab-aaty) and its unbranded version to include the treatment of HS in patients aged 12 years and older and UV in pediatric patients aged 2 years ...

In participants with geographic atrophy due to age-related macular degeneration, a photovoltaic retina implant microarray (PRIMA) system leads to significant improvement in visual acuity.

The FDA has approved Epioxa™ HD 0.239% and Epioxa™ 0.177% for use in epithelium-on corneal collagen CXL for the treatment of ...

Among older women, achieving ≥4,000 steps per day even just one or two days per week is associated with better health outcomes.

The researchers found that during an average of 29.7 years of follow-up, one-third of participants developed neuropathy, 63% developed diabetes-related eye disease, and 10% developed nephropathy.

While the trial met its primary endpoint, the FDA stated in its letter that the application could not be approved in its current form.

HealthDay News — Machine learning (ML) outperforms human graders for diagnosing glaucoma, according to a study presented at the annual meeting of the American Academy of Ophthalmology, held from Oct.

Pilocarpine 1.25% can boost distance corrected near visual acuity among other measures, in presbyopic adult eyes with dark irides.

Health professionals are screening and advising fewer than half of youth about tobacco use. HealthDay News — Health professionals are screening and advising fewer than half of youth about tobacco use, ...

Multifocal intraocular lenses may offer patients with mild-to-moderate glaucoma greater spectacle independence.

Older adults with visual impairment are significantly more likely to have difficulty leaving their homes, research shows.